Key statistics
On Wednesday, Ligand Pharmaceuticals Inc (LGNZZ:PKC) closed at 0.150, -23.47% below its 52-week high of 0.196, set on Jul 16, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.14 |
---|---|
High | 0.150 |
Low | 0.14 |
Bid | -- |
Offer | -- |
Previous close | 0.150 |
Average volume | 4.52k |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Nov 13 2024 20:34 GMT.
More ▼
Press releases
- Ligand to Present at Stifel 2024 Healthcare Conference
- Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance
- Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston
- Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024
- Ligand Partner Travere Therapeutics Receives Full FDA Approval for FILSPARI® (sparsentan), the Only Non-Immunosuppressive Treatment that Significantly Slows Kidney Function Decline in IgA Nephropathy
More ▼